CLYM CLIMB BIO INC
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 19 analyst firms say about CLIMB BIO INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
20 rated views · 21 analyst/firm records · 19 firms
Radar score
- Russell 2000 · Top Picks · 6MStrong · #17 in the index90
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8064
Recent analyst activity · last 90 days
Our tracked history has 20 reports on CLYM from 13 analyst firms in the last 90 days (19 firms in the past year).
Comparing each firm's latest target with its previous one: 3 raised their price target, 7 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Wedbush raised its target from $20.00 (set 19 Aug 2026) to $25.00 on 26 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| B Riley Securities | Mayank Mamtani | Buy | 3 Sep 2026 | 30.00 USD |
| Baird | Brian P Skorney | Buy | 17 Aug 2026 | 25.00 USD |
| Baird | Colleen Kusy | Buy | 3 Sep 2026 | 25.00 USD |
| BTIG | Julian Harrison | Buy | 27 Oct 2026 | 32.00 USD |
| Chardan Capital Markets | Geulah Livshits | Buy | 5 May 2026 | 22.00 USD |
| Deutsche Bank | David Hoang | Buy | 20 Oct 2026 | 28.00 USD |
| Freedom Capital Markets | Ilya Zubkov | Buy | 14 May 2026 | 20.00 USD |
| Guggenheim | Yastin Suneja | Buy | 26 Oct 2026 | 35.00 USD |
| H.C. Wainwright | Raghuram Selvaraju | Buy | 12 Oct 2026 | 30.00 USD |
| Leerink Partners | Thomas J Smith | Buy | 6 Aug 2026 | 28.00 USD |
| Mizuho | Graig Suvannavejh | Buy | 16 Sep 2026 | 18.00 USD |
| Mizuho | Joseph Catanzaro | Buy | 16 Sep 2026 | — |
| Oppenheimer | Leland Gershell | Buy | 8 Sep 2026 | 25.00 USD |
| Piper Sandler | Yasmeen Rahimi | Buy | 27 Oct 2026 | 40.00 USD · 3 Sep 2026 |
| Raymond James | Christopher Raymond | Buy | 5 Oct 2026 | 34.00 USD |
| RBC Capital Markets | Nevin Varghese | Buy | 3 Aug 2026 | 23.00 USD |
| Truist | Danielle Brill | Buy | 7 Aug 2026 | 25.00 USD |
| Wedbush | Laura Chico | Buy | 26 Oct 2026 | 25.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| William Blair | Matt Phipps | Buy | 23 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 07:00 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.